FDA.reportPublic FDA data

octreotide 30 MG Injection

RxCUI
898601
RxNorm name
octreotide 30 MG Injection
Display name
octreotide 30 MG Injection
Full name
octreotide 30 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OCTREOTIDE ACETATEOCTREOTIDE ACETATEMylan Institutional LLCe5c21813-4714-4f23-be8b-765bd58f63b32026-01-21Warnings, Adverse reactionsExact identifier
rxcui: 898601
Sandostatin LAR DepotOCTREOTIDE ACETATENovartis Pharmaceuticals Corporationd0b7fe9e-7000-4b79-ba3b-291ce92c14f92025-12-22Warnings, Adverse reactionsExact identifier
rxcui: 898601
Octreotide AcetateOCTREOTIDE ACETATETeva Pharmaceuticals, Inc.d9739ea6-74de-4a41-a806-6e827a23cedb2024-07-30Warnings, Adverse reactionsExact identifier
rxcui: 898601

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
d0b7fe9e-7000-4b79-ba3b-291ce92c14f9octreotide 30 MG InjectionSCD29These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820251222
d0b7fe9e-7000-4b79-ba3b-291ce92c14f9octreotide (as octreotide acetate) 30 MG InjectionSY29These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820251222
d0b7fe9e-7000-4b79-ba3b-291ce92c14f9octreotide LAR 30 MG InjectionPSN29These highlights do not include all the information needed to use SANDOSTATIN LAR DEPOT safely and effectively. See full prescribing information for SANDOSTATIN LAR DEPOT. SANDOSTATIN ® LAR DEPOT (octreotide acetate) for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820251222
d9739ea6-74de-4a41-a806-6e827a23cedboctreotide 30 MG InjectionSCD5These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION . OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820240730
d9739ea6-74de-4a41-a806-6e827a23cedboctreotide LAR 30 MG InjectionPSN5These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION . OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820240730
d9739ea6-74de-4a41-a806-6e827a23cedboctreotide (as octreotide acetate) 30 MG InjectionSY5These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION . OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820240730
e5c21813-4714-4f23-be8b-765bd58f63b3octreotide 30 MG InjectionSCD1These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION. OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820260121
e5c21813-4714-4f23-be8b-765bd58f63b3octreotide (as octreotide acetate) 30 MG InjectionSY1These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION. OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820260121
e5c21813-4714-4f23-be8b-765bd58f63b3octreotide LAR 30 MG InjectionPSN1These highlights do not include all the information needed to use OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION safely and effectively. See full prescribing information for OCTREOTIDE ACETATE FOR INJECTABLE SUSPENSION. OCTREOTIDE ACETATE for injectable suspension, for gluteal intramuscular use Initial U.S. Approval: 198820260121